BR100 Increased By (0.08%)
BR30 Increased By (0.57%)
KSE100 Increased By (0.28%)
KSE30 Increased By (0.29%)
AGHA 6.35 Increased By ▲ 0.03 (0.47%)
BECO 4.39 Increased By ▲ 0.12 (2.81%)
BML 62.50 Increased By ▲ 0.05 (0.08%)
BOP 31.47 Increased By ▲ 0.24 (0.77%)
CNERGY 11.70 Increased By ▲ 0.11 (0.95%)
CSIL 5.92 Increased By ▲ 0.20 (3.5%)
FCCL 61.60 Increased By ▲ 0.06 (0.1%)
FFL 14.79 Decreased By ▼ -0.23 (-1.53%)
FNEL 1.23 No Change ▼ 0.00 (0%)
KEL 6.33 Increased By ▲ 0.07 (1.12%)
KOSM 5.90 Increased By ▲ 0.34 (6.12%)
LOTCHEM 24.79 Increased By ▲ 0.11 (0.45%)
MLCF 103.93 Decreased By ▼ -0.15 (-0.14%)
NBP 173.05 Decreased By ▼ -2.23 (-1.27%)
NCPL 51.85 Decreased By ▼ -0.92 (-1.74%)
NPL 54.19 Increased By ▲ 0.07 (0.13%)
OGDC 315.50 Increased By ▲ 2.11 (0.67%)
PACE 9.26 Increased By ▲ 0.06 (0.65%)
PAEL 35.51 Decreased By ▼ -0.29 (-0.81%)
PIBTL 13.65 Increased By ▲ 0.18 (1.34%)
PPL 226.60 Increased By ▲ 4.79 (2.16%)
PRL 80.30 Increased By ▲ 1.22 (1.54%)
PTC 46.89 Increased By ▲ 0.04 (0.09%)
SSGC 23.90 Increased By ▲ 0.03 (0.13%)
TBL 9.30 Decreased By ▼ -0.01 (-0.11%)
TELE 7.65 Increased By ▲ 0.26 (3.52%)
TPL 24.51 Decreased By ▼ -0.60 (-2.39%)
TPLP 13.04 Increased By ▲ 0.53 (4.24%)
TREET 26.05 Decreased By ▼ -0.20 (-0.76%)
TRG 53.38 Decreased By ▼ -0.06 (-0.11%)
World

Abu Dhabi seeking volunteers for Russian COVID-19 vaccine trial

  • Russia on Saturday began distributing the vaccine to the most exposed groups in the country, the start of the first large-scale vaccination against the disease there.
Published Updated
By

DUBAI: Abu Dhabi is seeking volunteers to take part in Phase 3 clinical trials of Russia's COVID-19 vaccine, known as Sputnik V, in the capital of the United Arab Emirates.

Two doses of the vaccine will be given to up to 500 initial volunteers, according to the emirate's media office.

Russia on Saturday began distributing the vaccine to the most exposed groups in the country, the start of the first large-scale vaccination against the disease there.

Russia has developed two COVID-19 vaccines, Sputnik V which is backed by the Russian Direct Investment Fund and another developed by Siberia's Vector Institute, with final trials for the both yet to be completed.

The UAE is also conducting Phase 3 clinical trials of a COVID-19 vaccine developed by Chinese state-owned pharmaceutical company Sinopharm, and has approved emergency use of the vaccine for certain groups.

The UAE, population of around 9 million, has reported 177,577 cases and 594 COVID-19 deaths.

Comments

Comments are closed for this article.